» Articles » PMID: 32529922

Wound Healing of Metastatic Perineal Crohn's Disease Using Hyperbaric Oxygen Therapy: A Case Series

Overview
Publisher Wiley
Specialty Gastroenterology
Date 2020 Jun 13
PMID 32529922
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Metastatic Crohn's disease (CD) is a rare manifestation of CD. It involves inflammatory skin lesions with histopathological findings (granulomas) similar to CD, without connection to the gastrointestinal tract. Hyperbaric oxygen therapy (HBO) has been suggested as a possible treatment option.

Objective: This study aimed to identify and treat a consecutive series of patients with biopsy-proven metastatic CD and monitor wound healing using prospectively acquired outcomes.

Methods: Pathology results of all patients with ongoing perineal wound-healing problems after proctectomy between 2005 and 2018 at the Amsterdam University Medical Centre were assessed for metastatic CD. Patients with a biopsy-proven diagnosis of perineal metastatic CD were offered HBO (40 daily sessions of 100% oxygen at 2.4 atmosphere absolute). Wound healing was monitored using photographs and standardised questionnaires (the Inflammatory Bowel Disease Questionnaire, EuroQol Visual Analogue Scale and the Female Sexual Function Index) at baseline and 1 and 3 months after HBO.

Results: Out of 13 patients in the cohort with persisting perineal wounds after proctectomy, six (46%) had biopsy results consistent with metastatic CD. Of these, three accepted treatment with HBO. All three patients were female. One patient had complete healing of her perineal wound; another patient showed initial improvement but had a flare of luminal and perineal disease at the 3-month follow-up. The third patient showed improvement solely in the questionnaires, with higher scores on all three questionnaires.

Conclusion: A high rate of metastatic CD was found in patients with ongoing wound-healing problems after proctectomy, implying that the disease might not be as rare in these selected patients as previously thought. HBO might be beneficial in the treatment of metastatic CD.

Citing Articles

Hyperbaric Oxygen Therapy in the Treatment of Crohn's Disease.

Krstulovic J, Augustin G, Romic I, Tavra A, Batinovic F, Hrgovic Z Healthcare (Basel). 2025; 13(2).

PMID: 39857155 PMC: 11765433. DOI: 10.3390/healthcare13020128.


Emerging Indications for Hyperbaric Oxygen Treatment: Registry Cohort Study.

Tanaka H, Rees J, Zhang Z, Ptak J, Hannigan P, Silverman E Interact J Med Res. 2024; 13:e53821.

PMID: 39078624 PMC: 11372337. DOI: 10.2196/53821.


Fistulising skin metastases in Crohn's disease: a case report and review of the literature.

Elger T, Loibl J, Buechler C, Haferkamp S, Werner J, Drexler K J Med Case Rep. 2024; 18(1):252.

PMID: 38762485 PMC: 11102623. DOI: 10.1186/s13256-024-04569-1.


The new insights of hyperbaric oxygen therapy: focus on inflammatory bowel disease.

Chen L, Wang Y, Zhou H, Liang Y, Zhu F, Zhou G Precis Clin Med. 2024; 7(1):pbae001.

PMID: 38344218 PMC: 10858389. DOI: 10.1093/pcmedi/pbae001.


Addition of hyperbaric oxygen therapy versus usual care alone for inflammatory bowel disease: A systematic review and meta-analysis.

You J, Jiang J, He W, Ma H, Zhou M, Chen X Heliyon. 2022; 8(10):e11007.

PMID: 36276722 PMC: 9583108. DOI: 10.1016/j.heliyon.2022.e11007.


References
1.
Weisz G, Lavy A, Adir Y, Melamed Y, Rubin D, Eidelman S . Modification of in vivo and in vitro TNF-alpha, IL-1, and IL-6 secretion by circulating monocytes during hyperbaric oxygen treatment in patients with perianal Crohn's disease. J Clin Immunol. 1997; 17(2):154-9. DOI: 10.1023/a:1027378532003. View

2.
Camporesi E . Side effects of hyperbaric oxygen therapy. Undersea Hyperb Med. 2014; 41(3):253-7. View

3.
de Groof E, van der Meer J, Tanis P, de Bruyn J, van Ruler O, DHaens G . Persistent Mesorectal Inflammatory Activity is Associated With Complications After Proctectomy in Crohn's Disease. J Crohns Colitis. 2018; 13(3):285-293. DOI: 10.1093/ecco-jcc/jjy131. View

4.
Juan W, Chan Y, Lee J, Yang L, Hong H, Yang C . Livedoid vasculopathy: long-term follow-up results following hyperbaric oxygen therapy. Br J Dermatol. 2006; 154(2):251-5. DOI: 10.1111/j.1365-2133.2005.06843.x. View

5.
McCulloch N, Wojcik S, Heyboer 3rd M . Patient Outcomes and Factors Associated with Healing in Calciphylaxis Patients Undergoing Adjunctive Hyperbaric Oxygen Therapy. J Am Coll Clin Wound Spec. 2017; 7(1-3):8-12. PMC: 5197060. DOI: 10.1016/j.jccw.2016.08.004. View